DiaSorin Molecular Launches New Simplexa™ Bordetella Direct Molecular Test
DiaSorin Molecular LLC receives CE Mark for a new Bordetella molecular diagnostic test. Simplexa™ Bordetella Direct is designed to quickly provide qualitative detection and differentiation of both Bordetella pertussis and Bordetella parapertussis in human nasopharyngealswabs.